Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsStructural features and kinetic characterization of alanine racemase fromStaphylococcus aureus(Mu50)Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus PersistersWhole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureusNewly Isolated Paenibacillus tyrfis sp. nov., from Malaysian Tropical Peat Swamp Soil with Broad Spectrum Antimicrobial Activity.In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolatesDaptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanismsClinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens.Daptomycin therapy for osteomyelitis: a retrospective study.Antibiotic options for treating community-acquired MRSA.Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies.Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure.In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitalsGenetics of antimicrobial resistance in Staphylococcus aureus.Current and novel antibiotics against resistant Gram-positive bacteriaCeftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA)Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation.Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype.Pharmacological inhibition of the ClpXP protease increases bacterial susceptibility to host cathelicidin antimicrobial peptides and cell envelope-active antibiotics.In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model.Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.Daptomycin-nonsusceptible, vancomycin-intermediate, methicillin-resistant Staphylococcus aureus endocarditis.Impact of daptomycin resistance on Staphylococcus aureus virulence.Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.Targeting bacterial membrane function: an underexploited mechanism for treating persistent infectionsFailures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.Mechanisms of resistance to daptomycin in Enterococcus faecium.Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in TaiwanBiochemical characterization of cardiolipin synthase mutations associated with daptomycin resistance in enterococci.Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.
P2860
Q24646677-2F2E4AF8-6BC2-44A1-838A-75AB188517CEQ27676379-3E67C9C3-742D-44D2-8CDB-4E6EE4929368Q28550612-CFAB139E-BB41-4A0E-A1B5-72C7ABB19DD1Q28740293-D5830B93-9B80-4641-A0B0-9FAD7E595A57Q31057909-C7624643-9A46-4562-9488-BB4BA1D4A097Q33876626-C097EF3A-9CDE-43C1-BE2F-0989681E74F7Q34045273-1B628814-B090-4C20-8465-1DA1F9C4F004Q34045376-8CB61251-D758-49E0-8F8C-9C9E1E5F1813Q34157657-A758107C-6243-4D17-93FB-DFB8677A79F2Q34293608-8E5638B8-A425-4B86-8092-23F7FFF0E9CCQ34301398-EFFB2290-675E-4D2F-BE7D-3F7EFA582648Q34593646-487E51A0-F206-4B25-A745-381C982AA7EBQ34597770-25D5C97B-083C-45A7-95BA-EFF96748E9B8Q34648042-73A8C06C-B403-477E-8A57-0D603EDB09FDQ34680589-E71CFEE4-D9EF-4CF9-B62F-976EF4552C66Q34779009-CA116F5D-8EED-4E81-A10E-8DEA521B0A5CQ34932588-E7C5A880-B7BD-4E25-8A72-F6C317854D31Q34973784-770D7C88-6545-47E9-97B8-672BAAA1999BQ34984662-F3330A64-C6E3-4D18-9BA3-9DBCFD808197Q35026521-32200F40-FDF4-4535-902B-C6E640D7E311Q35117981-009938AF-56C5-42C1-9B1B-16CBDE3E5418Q35139449-A12AA0A2-2F0C-4660-9AC2-2460DB87517CQ35169018-B21FD783-F5A8-45F3-A07F-34DFB4F9170AQ35256159-A1F1700D-6547-4B9A-A325-03A04849E0D2Q35619094-D2563F7C-A17D-411A-80D0-646FE3B08BD8Q35689222-98E5B398-FAAD-4662-B9A4-CA26720AD8D0Q35722282-93AA9971-1C17-4A65-A66A-022605328913Q35746096-719328EF-E8FE-4BB7-9265-BB9B1DB7A81CQ35867517-1A79125C-F98F-411F-B85E-DD073159CCA8Q36076047-B7B47948-08E9-4F2A-BB93-2A9E27DC358EQ36094925-08532C53-8D55-4F58-83F2-FE83D08C77EDQ36111786-31F76BCE-1ED5-42E2-B150-13E07E642606Q36147127-495DA361-8A12-4511-AD16-81DD7C8C20CFQ36364106-32698D6B-A835-4FD5-B465-9857CB4E894AQ36393640-DDAD30B4-C027-4371-BA07-C40CC1EFBA6EQ36422686-64972322-EA56-4162-AAF0-5272AA2FDD77Q36482920-47821CAC-E482-44E5-929A-CBA4CCDD9EF0Q36497876-53161A2D-BDC2-4BEE-8058-0152C94A16D4Q36505466-4B0BFC37-42F2-4E87-A85E-958569CAD863Q36565462-2F35BCED-0CEF-4DEB-849C-39937A59EE76
P2860
Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Development of Daptomycin resi ...... esistant Staphylococcus aureus
@ast
Development of Daptomycin resi ...... esistant Staphylococcus aureus
@en
Development of Daptomycin resi ...... esistant Staphylococcus aureus
@nl
type
label
Development of Daptomycin resi ...... esistant Staphylococcus aureus
@ast
Development of Daptomycin resi ...... esistant Staphylococcus aureus
@en
Development of Daptomycin resi ...... esistant Staphylococcus aureus
@nl
prefLabel
Development of Daptomycin resi ...... esistant Staphylococcus aureus
@ast
Development of Daptomycin resi ...... esistant Staphylococcus aureus
@en
Development of Daptomycin resi ...... esistant Staphylococcus aureus
@nl
P2093
P2860
P1476
Development of Daptomycin resi ...... esistant Staphylococcus aureus
@en
P2093
P2860
P304
P356
10.1128/JCM.43.10.5285-5287.2005
P407
P577
2005-10-01T00:00:00Z